1. Effect of prescription omega-3 fatty acids coadministered with escalating doses of atorvastatin in patients with hypertriglyceridemia [abstract 5150];Bays;Circulation,2008
2. Bays HE, McKenney J, Doyle RT, Carter RN, Stein E. Prescription omega-3s coadministered with atorvastatin for patients with hypertriglyceridemia. Encore poster presented at: American Association of Diabetes Educators 2009 Annual Meeting; August 5-8, 2009, Atlanta, GA.
3. Bays HE, McKenney J, Doyle RT, Carter RN, Stein E. Effect of prescription omega-3 fatty acids coadministered with escalating doses of atorvastatin on non-HDL-C in patients with hypertriglyceridemia. Encore poster presented at: American College of Clinical Pharmacy Annual Meeting 2009, Anaheim, CA, October 18-21, 2009.
4. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report;National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III);Circulation,2002
5. Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation;Brunzell;J Am Coll Cardiol,2008